Skip to content

8box Solutions Inc.


Contact Number: 09369340340

Home » RMC No. 59-2022

RMC No. 59-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 59-2022 issued on April 27, 2022 publishes the March 4, 2022 letter from Food and Drug Administration OIC-Director General, Dr. Oscar G. Gutierrez, Jr. endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act). The List now includes certain medicines for cancer and COVID19 treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *